TFF PHARMACEUTICALS INC's ticker is TFFP and the CUSIP is 87241J104. A total of 46 filers reported holding TFF PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $74,580 | -25.8% | 213,085 | -0.4% | 0.00% | – |
Q2 2023 | $100,532 | -46.4% | 213,898 | -21.8% | 0.00% | – |
Q1 2023 | $187,388 | -31.3% | 273,441 | +5.3% | 0.00% | – |
Q4 2022 | $272,780 | -74.1% | 259,790 | +0.3% | 0.00% | – |
Q3 2022 | $1,052,000 | -28.7% | 259,136 | -0.7% | 0.00% | – |
Q2 2022 | $1,475,000 | -9.2% | 260,990 | +1.3% | 0.00% | – |
Q1 2022 | $1,625,000 | -28.9% | 257,670 | +0.1% | 0.00% | – |
Q4 2021 | $2,284,000 | +14.1% | 257,499 | -0.7% | 0.00% | – |
Q3 2021 | $2,001,000 | -20.4% | 259,270 | -0.9% | 0.00% | – |
Q2 2021 | $2,514,000 | -35.0% | 261,514 | -8.2% | 0.00% | – |
Q1 2021 | $3,867,000 | -3.5% | 284,921 | +1.8% | 0.00% | – |
Q4 2020 | $4,008,000 | -14.7% | 279,846 | +10.1% | 0.00% | – |
Q3 2020 | $4,696,000 | +1455.0% | 254,209 | +384.3% | 0.00% | – |
Q2 2020 | $302,000 | +259.5% | 52,494 | +137.2% | 0.00% | – |
Q1 2020 | $84,000 | +25.4% | 22,134 | +77.8% | 0.00% | – |
Q4 2019 | $67,000 | – | 12,452 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Corriente Advisors, LLC | 1,058,823 | $19,556,000 | 9.92% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 220,666 | $4,076,000 | 4.24% |
Mesirow Financial Investment Management, Inc. | 34,902 | $645,000 | 2.76% |
Gagnon Advisors, LLC | 176,471 | $3,259,000 | 2.00% |
Nantahala Capital Management | 2,032,988 | $37,549,000 | 1.15% |
PRECEPT MANAGEMENT LLC | 235,294 | $4,346,000 | 1.07% |
GAGNON SECURITIES LLC | 219,584 | $4,056,000 | 0.86% |
Sepio Capital, LP | 84,560 | $1,562,000 | 0.17% |
683 Capital Management, LLC | 117,647 | $2,173,000 | 0.16% |
SANDERS MORRIS HARRIS LLC | 21,326 | $340,000 | 0.09% |